UNSPSC 51361924: Vinbarbital

This classification denotes a barbiturate with the molecular formula C11H16N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7NZH2C1T6O, chemically known as 2,4,6(1h, 3h,5h)-pyrimidinetrione, 5-ethyl-5-(1-methyl-1-butenyl)-, sodium salt but generally known as vinbarbital, which bears US NIH Compound Identifier 5284636. European Medicines Agency schedules Vinbarbital in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00051MIG. The term VINBARBITAL is an International Non-Proprietary Name.

UNSPSC 51361924 Vinbarbital, a Commodity code, nominally covers a specific barbiturate pharmaceutical, but recent state and local solicitations tagged under this code show minimal activity directly aligned with vinbarbital procurement. Instead, the code appears in opportunities focused on broader pharmaceutical and drug-management products—naloxone procurement, generic multi-source pharmaceuticals and OTC products through cooperative purchasing alliances, and direct-to-manufacturer prescription program design. State and local issuing bodies soliciting under or near this code span county health departments (Seminole County, Florida), state HHS commissions (Texas), and multistate cooperative purchasing organizations (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The work involves purchasing finished pharmaceuticals and related drug-management systems for community health initiatives, pharmacy benefit programs, and employee health plans, typically bundled through authorized wholesalers or direct manufacturer relationships rather than as single-ingredient pharmaceutical inputs.

Recent activity clusters in Florida and Minnesota, with Texas conducting exploratory procurement for pharmacy direct-contracting models. Seminole County issued IFB 60459723LAS on June 30, 2026 (response due July 26, 2023, per the historical posting), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a two-year initial term plus one-year renewal option. MMCAP, administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities including Oregon, with awarded vendors effective July 1, 2026, and pricing weighted at 75 percent of evaluation. Texas HHS Commission posted RFI HHS0017013 on April 3, 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program—an information-gathering phase preceding formal procurement. The code shows light direct alignment with vinbarbital-specific demand; the tagging appears to reflect broader pharmaceutical and drug-management category handling rather than dedicated barbiturate sourcing.